← Back to Search

Other

Nebulized KELEA Water for COVID-19

N/A
Waitlist Available
Led By W John Martin, MD, PhD
Research Sponsored by Institute of Progressive Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Preferably symptomatic for Covid-19
Individuals entering into quarantine because of a positive Covid-19 test using either PCR or an authorized antigen assay
Timeline
Screening 3 weeks
Treatment Varies
Follow Up two consecutive 2-days periods of sequential inhalation of test and control water in randomized order.
Awards & highlights

Study Summary

This trial is looking at whether or not inhaling a nebulized mist from water can help lessen symptoms of Covid-19 and if there are any adverse effects.

Who is the study for?
This trial is for people who have tested positive for COVID-19, preferably showing symptoms, and are entering quarantine. They must be willing to undergo repeat PCR or antigen testing and share the results along with their clinical data.Check my eligibility
What is being tested?
The study tests inhaling nebulized mist from KELEA Excellerated Water versus regular water without elevated KELEA levels. Participants will use a nebulizer or humidifier over two consecutive days and get tested for COVID-19 after each period.See study design
What are the potential side effects?
There are no known adverse effects reported from inhaling the water mist using a nebulizer or humidifier in this context.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am showing symptoms of Covid-19.
Select...
I am going into quarantine due to a positive Covid-19 test.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~two consecutive 2-days periods of sequential inhalation of test and control water in randomized order.
This trial's timeline: 3 weeks for screening, Varies for treatment, and two consecutive 2-days periods of sequential inhalation of test and control water in randomized order. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Treated Then Control WaterActive Control2 Interventions
This Arm includes half of the total randomly allocated participants in the study. Participants will initially inhale KELEA Excellerated Water for 2 days followed by inhaling water without an elevated level of KELEA for 2 days, with Covid-19 testing and symptom assessments performed at the ends of both of the 2 days periods.
Group II: Control Than Treated WaterPlacebo Group2 Interventions
This Arm includes half of the total randomly allocated participants in the study. Participants will initially inhale water without an elevated level of KELEA for 2 days followed by inhaling KELEA Excellerated water for 2 days, with Covid-19 testing and symptom assessments performed at the ends of both of the 2 days periods.

Find a Location

Who is running the clinical trial?

Institute of Progressive MedicineLead Sponsor
1 Previous Clinical Trials
500 Total Patients Enrolled
W John Martin, MD, PhDPrincipal InvestigatorMedical Director
1 Previous Clinical Trials
500 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available openings for this clinical trial?

"According to the clinicaltrials.gov website, this particular trial is not actively recruiting patients at this time. The study was initially posted on October 1st 2020 and was most recently updated on August 5th 2022. Although this specific trial is not enrolling candidates anymore, there are 1233 other studies currently accepting patients."

Answered by AI
~5 spots leftby Mar 2025